South Africa: SAHPRA Issues Guidance for Clinical Trials Impacted by COVID-19
March 27, 2020
On March 25, 2020, the South African Health Products Regulatory Authority (SAHPRA) issued SAHPRA Policy on Conduct of Clinical Trials of Health Products during the Current COVID-19 Pandemic. The guidance covers items such as participant safety, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity.